drugset / Trial / NCT00427596

A Two-Part Study to Determine: Best Medication Formulation and Food Effect

NCT00427596

Phase 1 Completed 18 enrolled GlaxoSmithKline
RandomizedCrossoverOpen-labelTreatment

Summary

This is a two-part study. Part 1 is designed to find the best modified release formulation of GW423753; Part 2 is designed to use the selected formulation(s) from Part 1 to find out if food affects the way the medication is processed by the body.

Timeline

Start
2007-01
Primary completion
2007-08
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Solabegron Unknown

Indications